Tripartite Therapeutics Inc. (TPEX:7920)
Taiwan · Delayed Price · Currency is TWD 14.60
+0.75 (5.42%)
At close: Jun 12, 2026
Tripartite Therapeutics Market Cap
Tripartite Therapeutics has a market cap or net worth of 8.67 billion as of June 12, 2026.
Market Cap
8.67B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.60
Market Cap Chart
Since May 20, 2026, Tripartite Therapeutics's market cap has increased from 4.21B to 8.67B, an increase of 106.21%. That is a compound annual growth rate of 9,729,956.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 8.67B | 5.42% |
| Jun 11, 2026 | 8.23B | -5.14% |
| Jun 10, 2026 | 8.67B | -7.59% |
| Jun 9, 2026 | 9.39B | 2.60% |
| Jun 8, 2026 | 9.15B | -15.38% |
| Jun 5, 2026 | 10.81B | 8.66% |
| Jun 4, 2026 | 9.95B | 32.94% |
| Jun 3, 2026 | 7.48B | 30.84% |
| Jun 2, 2026 | 5.72B | 11.85% |
| Jun 1, 2026 | 5.11B | 3.73% |
| May 29, 2026 | 4.93B | 3.49% |
| May 28, 2026 | 4.76B | -1.60% |
| May 27, 2026 | 4.84B | -2.40% |
| May 26, 2026 | 4.96B | 19.63% |
| May 25, 2026 | 4.15B | 13.68% |
| May 22, 2026 | 3.65B | 1.82% |
| May 21, 2026 | 3.58B | -14.83% |
| May 20, 2026 | 4.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 20.80B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.60B |
| Intelligene | 6.50B |
| Uwell Biopharma | 6.47B |
| Obigen Pharma | 3.93B |
| Pet Pharm Biotech | 2.88B |
| BIONET Therapeutics | 2.61B |
| Genomics BioSci & Tech. | 1.18B |